2014
DOI: 10.1016/j.jviromet.2014.06.014
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of UL99 transcript as a target for antiviral treatment efficacy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…For the study of HCMV, the UL99 transcript has been identified as a rapid marker of therapy effectiveness. Through a qRT-PCR assay analysis of 18 bronchoalveolar lavage samples from patients who were or were not subjected to antiviral treatment in vivo and vitro, UL99 has been developed as an antiviral control (Gambarino et al, 2014). In the past, it was difficult to study L gene promoters, as they were expressed in a disorderly fashion in transient assays (Kohler et al, 1994).…”
Section: Other Functions Of Ul11mentioning
confidence: 99%
“…For the study of HCMV, the UL99 transcript has been identified as a rapid marker of therapy effectiveness. Through a qRT-PCR assay analysis of 18 bronchoalveolar lavage samples from patients who were or were not subjected to antiviral treatment in vivo and vitro, UL99 has been developed as an antiviral control (Gambarino et al, 2014). In the past, it was difficult to study L gene promoters, as they were expressed in a disorderly fashion in transient assays (Kohler et al, 1994).…”
Section: Other Functions Of Ul11mentioning
confidence: 99%